You are here: Industry Insights > AI

News List

Atomwise leverages AI to explore broad-spectrum Covid-19 drugs pharmaceutical-technology
May 26, 2020
Atomwise has forged fifteen research collaborations with universities globally to develop broad-spectrum treatments for Covid-19, as well as other coronaviruses.
Ultromics, Mayo Clinic Collaborate to Rapidly Assess COVID-19 Patients Using AI americanpharmaceuticalreview
May 13, 2020
A joint UK-US research team is applying an artificial intelligence system to map for the first time how the COVID-19 virus attacks the heart with such deadly impact.
Aberdeen Uni proceeds with COVID-19 mass screening research pharmatimes
May 07, 2020
Researchers at the University of Aberdeen plan to use artificial intelligence (AI) to try to fast-track a test to allow mass screening for COVID-19, after the ￡140,000 project was approved by the Scottish government.
Technology has driven success in pharma industry in many perceptible ways expresspharma
April 30, 2020
Gyan Pandey, Global and Group CIO, Aurobindo Pharma, explains that digitalisation is not a one-time process, but an evolving journey.
AI can play a big role in vaccine development for COVID-19 expresspharma
April 30, 2020
Many believe that AI has the potential to complement the scientific community in major breakthroughs, especially in developing vaccines for COVID-19.
Real-world evidence the most impactful emerging technology in COVID-19 management: Poll pharmaceutical-technology
April 23, 2020
New-age emerging technologies are projected to have a significant impact on managing the coronavirus pandemic (COVID-19).
Pharnext, UHI to Evaluate Repurposed Drugs Against COVID-19 contractpharma
April 23, 2020
Aims to rapidly test several approved drugs as potential candidates for fighting COVID-19 using big data and artificial intelligence.
Insilico and Boehringer to use AI for drug targets discovery pharmaceutical-technology
April 16, 2020
Boehringer partners Insilico for AI-based discovery of drug targets. Insilico Medicine has partnered with Boehringer Ingelheim.
Experimental AI tool predicts which COVID-19 patients develop respiratory disease worldpharmanews
March 31, 2020
An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.
XtalPi Collaborates with Porton contractpharma
March 13, 2020
Combining AI algorithms with targeted experiments to solve bottleneck challenges in drug development.